A major drug maker is making strides against malaria and a local biotech company is a big part of that success.
Epizyme stock soared on Tuesday, after the company announced two important payments from its partners in the development of new types of cancer drugs.
Massachusetts is getting more than $2.1 million to settle claims that British drug maker GlaxoSmithKline LLC deceptively promoted the diabetes drug Avandia.
An agreement by British drugmaker GlaxoSmithKline to pay $3 billion for criminal and civil violations involving 10 drugs that are taken by millions of people has been approved by a federal judge
GlaxoSmithKline LLC will pay $3 billion in the largest health care fraud settlement in U.S. history, the Justice Department said Monday.